Purchase Order 75N95C19P00066

<p>The National Center for Advancing Translational Sciences issued a purchase order to Promega Corporation for $14,428.60, awarded September 24, 2019, with ultimate completion October 30, 2019. No set-aside was used. Work is performed at Promega's Madison, Wisconsin facility. The order is firm fixed price. Specific requirements are not detailed in the source.</p>

This is a $127,908.40 firm fixed-price purchase order awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The award is for Promega's proprietary reagent kits and assay products, which are sole source procured due to their specialized capabilities required to support NCATS' ongoing laboratory research and high-throughput screening programs. This award was not...

This is a $83,800 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Promega Corporation. The award is to procure custom Promega assays and reagents, including the MTase-Glo Methyltransferase Assay, to support NCATS's Antiviral Program for Pandemics. The award is non-competitive as Promega's reagents are specifically engineered and optimized for NCATS's high-throughput screening and...

This firm-fixed-price purchase order was awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS) within the Department of Health and Human Services' National Institutes of Health. The $121,492.50 contract is for the procurement of detection assay systems with an August 2021 completion date. Promega has previously been awarded prime and subcontracts by various agencies including the NIH, CDC, DoD, and FBI to provide DNA...

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Promega Corporation for a methyltransferase assay kit, consisting of 2,000 assays. The $45,504.00 contract is to support NCATS' mission of catalyzing innovative methods and technologies for developing diagnostics and therapeutics. The assay kits will be used in NCATS' methyltransferase project to identify...

Promega Corporation received a contract award valued at $21,260 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health, on April 12, 2016. This firm fixed-price BPA (Blanket Purchase Agreement) call was issued without small business set-aside designation and required performance in Madison, Wisconsin, with completion by February 28, 2017. The contract procures specialized kinase assay products including ADP-Glo Kinase Assay kits...

This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) on behalf of the National Center for Advancing Translational Sciences (NCATS) to Promega Corporation, a global life sciences company. The $83,800 contract is for the procurement of Promega reagents and assays to support NCATS' Antiviral Program for Pandemics. The award does not utilize a set-aside designation. The original solicitation states that NCATS' screening assays have been optimized using Promega...

The National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed price purchase order to Promega Corporation for $24,640.20 to supply 18 units of Promega CellTiter-Glo(R) One Solution Assay 500 ml, a one-step, homogenous reagent used to detect ATP levels without additional reagents. The purchase order was awarded non-competitively on March 1, 2024 and delivery is required by March 14, 2024 to support various Early Translation Branch projects at the...

This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Promega Corporation for $132,961.50. The order is for Promega's cytochrome P450 screening assay systems to support the Tox21 drug screening program. The assay kits measure the activity of various CYP enzymes, which are critical for evaluating drug metabolism and toxicity. This award was sole-sourced to Promega as the sole...

Promega Corporation received a firm fixed-price Blanket Purchase Agreement (BPA) call order valued at $14,967.00 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The award, issued on February 23, 2015, with completion targeted for February 28, 2015, procures CellTiter-Glo Solution in quantities of 18 units. This product order was placed under Promega's existing $10 million NIH BPA, which covers biological materials,...